A detailed history of Huntington National Bank transactions in Becton Dickinson & CO stock. As of the latest transaction made, Huntington National Bank holds 17,286 shares of BDX stock, worth $3.84 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
17,286
Previous 18,061 4.29%
Holding current value
$3.84 Million
Previous $4.22 Million 1.28%
% of portfolio
0.03%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$221.47 - $242.41 $171,639 - $187,867
-775 Reduced 4.29%
17,286 $4.17 Million
Q2 2024

Aug 08, 2024

SELL
$225.07 - $246.17 $259,055 - $283,341
-1,151 Reduced 5.99%
18,061 $4.22 Million
Q1 2024

May 03, 2024

SELL
$233.45 - $247.73 $1.26 Million - $1.34 Million
-5,412 Reduced 21.98%
19,212 $4.75 Million
Q4 2023

Feb 07, 2024

SELL
$232.24 - $267.23 $13,702 - $15,766
-59 Reduced 0.24%
24,624 $6 Million
Q3 2023

Nov 08, 2023

BUY
$254.9 - $283.59 $927,836 - $1.03 Million
3,640 Added 17.3%
24,683 $6.38 Million
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $398,826 - $443,880
-1,673 Reduced 7.36%
21,043 $5.56 Million
Q1 2023

May 10, 2023

SELL
$229.71 - $259.35 $484,458 - $546,969
-2,109 Reduced 8.5%
22,716 $5.62 Million
Q4 2022

Feb 09, 2023

SELL
$218.29 - $256.91 $231,605 - $272,581
-1,061 Reduced 4.1%
24,825 $6.31 Million
Q3 2022

Nov 07, 2022

SELL
$51.03 - $264.23 $58,939 - $305,185
-1,155 Reduced 4.27%
25,886 $5.77 Million
Q2 2022

Aug 09, 2022

SELL
$234.74 - $275.42 $58,215 - $68,304
-248 Reduced 0.91%
27,041 $6.67 Million
Q1 2022

May 10, 2022

SELL
$243.64 - $270.48 $171,035 - $189,876
-702 Reduced 2.51%
27,289 $7.26 Million
Q4 2021

Jan 21, 2022

SELL
$230.08 - $250.94 $307,156 - $335,004
-1,335 Reduced 4.55%
27,991 $7.04 Million
Q3 2021

Oct 28, 2021

SELL
$232.72 - $256.47 $539,677 - $594,753
-2,319 Reduced 7.33%
29,326 $7.21 Million
Q2 2021

Jul 30, 2021

SELL
$232.65 - $254.58 $70,027 - $76,628
-301 Reduced 0.94%
31,645 $7.7 Million
Q1 2021

Apr 12, 2021

SELL
$232.09 - $256.88 $963,405 - $1.07 Million
-4,151 Reduced 11.5%
31,946 $7.77 Million
Q4 2020

Jan 11, 2021

SELL
$221.92 - $245.94 $839,301 - $930,145
-3,782 Reduced 9.48%
36,097 $9.03 Million
Q3 2020

Oct 30, 2020

SELL
$215.77 - $276.76 $1.13 Million - $1.45 Million
-5,227 Reduced 11.59%
39,879 $9.28 Million
Q2 2020

Jul 30, 2020

SELL
$219.9 - $263.41 $1.24 Million - $1.49 Million
-5,646 Reduced 11.12%
45,106 $10.8 Million
Q1 2020

Apr 27, 2020

SELL
$195.69 - $279.01 $2.72 Million - $3.88 Million
-13,891 Reduced 21.49%
50,752 $11.7 Million
Q4 2019

Jan 17, 2020

BUY
$236.45 - $266.82 $168,115 - $189,709
711 Added 1.11%
64,643 $17.6 Million
Q3 2019

Nov 01, 2019

SELL
$230.58 - $256.08 $601,813 - $668,368
-2,610 Reduced 3.92%
63,932 $16.2 Million
Q2 2019

Jul 23, 2019

SELL
$217.4 - $246.08 $788,075 - $892,040
-3,625 Reduced 5.17%
66,542 $16.8 Million
Q1 2019

Apr 09, 2019

SELL
$206.05 - $248.17 $733,950 - $883,981
-3,562 Reduced 4.83%
70,167 $17.5 Million
Q4 2018

Jan 28, 2019

SELL
$204.73 - $257.93 $37,056 - $46,685
-181 Reduced 0.24%
73,729 $16.6 Million
Q3 2018

Oct 18, 2018

BUY
$233.07 - $256.0 $798,497 - $877,056
3,426 Added 4.86%
73,910 $19.3 Million
Q2 2018

Jul 19, 2018

SELL
$208.1 - $233.85 $1.62 Million - $1.83 Million
-7,806 Reduced 9.97%
70,484 $16.9 Million
Q1 2018

Apr 30, 2018

SELL
$205.46 - $240.27 $2.55 Million - $2.99 Million
-12,431 Reduced 13.7%
78,290 $17 Million
Q4 2017

Feb 02, 2018

SELL
$189.0 - $222.64 $10.5 Million - $12.3 Million
-55,304 Reduced 37.87%
90,721 $19.4 Million
Q3 2017

Oct 24, 2017

BUY
$186.89 - $198.9 $27.3 Million - $29 Million
146,025
146,025 $28.6 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.